Linio Biotech Receives Best Presentation Award at EATCB 2025
Award-Winning Presentation Highlights Linio Biotech’s Tience® Technology at EATCB
The Linio Biotech team participated in the 33rd Annual Congress of the European Association of Tissue and Cell Banks (EATCB), held in Tampere, Finland, from November 12–14, 2025. The congress brought together leading experts in tissue and cell banking, offering a platform for learning, knowledge exchange, and the presentation of the latest research advances and regulatory updates in the field.
Linio Biotech’s Preclinical Research Manager, Mimmi Patrikoski, PhD, delivered a presentation in the plenary session focused on new technologies. Her talk titled “From Autologous to Allogeneic Approach with Cell-Free Adipose Tissue Technology: Clinical Studies on Wound Healing and Scar Maturation,” highlighted the broad potential of Linio’s core technology, Tience®, in wound healing and scar maturation as demonstrated in clinical studies, along with key aspects of its manufacturing and quality control.
The presentation generated strong interest among participants and received the Best Presentation award from the EATCB Congress organizing committee at the closing ceremony. Overall, the audience showed great interest in Linio’s core technology, and its promising potential in tissue regeneration.
Linio Biotech Receives Best Presentation Award at EATCB 2025
Award-Winning Presentation Highlights Linio Biotech’s Tience® Technology at EATCB
The Linio Biotech team participated in the 33rd Annual Congress of the European Association of Tissue and Cell Banks (EATCB), held in Tampere, Finland, from November 12–14, 2025. The congress brought together leading experts in tissue and cell banking, offering a platform for learning, knowledge exchange, and the presentation of the latest research advances and regulatory updates in the field.
Linio Biotech’s Preclinical Research Manager, Mimmi Patrikoski, PhD, delivered a presentation in the plenary session focused on new technologies. Her talk titled “From Autologous to Allogeneic Approach with Cell-Free Adipose Tissue Technology: Clinical Studies on Wound Healing and Scar Maturation,” highlighted the broad potential of Linio’s core technology, Tience®, in wound healing and scar maturation as demonstrated in clinical studies, along with key aspects of its manufacturing and quality control.
The presentation generated strong interest among participants and received the Best Presentation award from the EATCB Congress organizing committee at the closing ceremony. Overall, the audience showed great interest in Linio’s core technology, and its promising potential in tissue regeneration.